18 Years
35 Years
Female
Polycystic Ovary Syndrome
Trial Information
It is planned to compare the values of FSH/LH, AMH, and 75 gr OGTT between 20 patients
diagnosed as PCOS according to the AES-Rotterdam criteria and 20 patients with multicystic
ovarian structure but do not provide the PCOS-D3 criteria. The second purpose of this study
is to investigate the mechanism that leads to the elevation of AMH in patients with PCOS,
and to reveal the effects of intraovarian paracrine factors,insulin resistance and FSH /LH.
Inclusion Criteria:
- Between the ages of 18-35
- >6 4-9 mm follicles in bilateral ovaries at ultrasonographic examination
- Increased ovarian volume (>10 ml )
Exclusion Criteria:
- Hormonal drug users
- Late onset congenital adrenal hyperplasia,androgen secreted ovarian or adrenal tumors
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Anti-Müllerian Hormone level 0.7ng/ml -3.5ng/ml.
Outcome Description:
difference of serum AMH levels between patients with PCO or multicystic ovaries
Outcome Time Frame:
6 months
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
AMH-123
NCT ID:
NCT01878955
Start Date:
April 2013
Completion Date:
August 2014
Related Keywords:
- Polycystic Ovary Syndrome
- Antimullarian hormone(AMH)
- Polycystic Ovary
- Multicystic Ovary
- Polycystic Ovary Syndrome
Name | Location |
|---|
